Cite Filings / TLSI / 0001628280-26-022127

Feed Companies Filings Check

Sign in

DEFA14A

Proxy Materials

TriSalus Life Sciences, Inc. Filed 2026-03-31 Acc 0001628280-26-022127

Documents 1

DEFA14A Proxy Materials , trisalus-2026proxyaddition.htm

Around this filing

2026-04-07 8-K Executive or director change · Regulation FD disclosure
2026-04-01 4 Director acquired 330,000 shares (conversion)
2026-03-31 ARS Annual Report to Security Holders
2026-03-31 DEFA14A Proxy Materials
2026-03-31 DEF 14A Proxy Statement
2023-08-02 DEFA14A Proxy Materials

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading trisalus-2026proxyaddition.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…